FDA to Host Public Conference on Serious Drug-Induced Liver Injury: Who Gets It? Who Doesn't? Why?

Summary

The FDA is hosting a public conference with the Critical Path Institute and the Pharmaceutical Research and Manufacturers of America to discuss how to detect and assess drug-induced liver injury in people taking medications for medical purposes.